Melanotan 1 vs 2: Key Differences (Beginner's Guide)

Melanotan 1 vs 2 explained for beginners: how the two tanning peptides differ in receptor targets, potency, side effects, and legal status.

Melanotan 1 and Melanotan 2 are two lab-made peptides that both copy a natural hormone in your body called alpha-melanocyte-stimulating hormone (alpha-MSH). The simplest way to tell them apart: Melanotan 1 is highly selective and acts mainly on one receptor tied to skin pigment, while Melanotan 2 is broader and acts on several receptors throughout the body. That single difference shapes almost everything else, including how each peptide is studied, how strong its side effects tend to be, and whether any form of it is legally approved.

If you have searched "melanotan 1 vs 2" and ended up confused by chemistry papers or alarming headlines, this guide is for you. It explains the comparison in plain language, walks through how each peptide works, and answers the questions people ask most. Everything below describes research and clinical findings only. Neither peptide is sold as an approved cosmetic product.

What Are Melanotan 1 and Melanotan 2?

Melanotan 1 and Melanotan 2 are synthetic (lab-made) versions of alpha-MSH, the hormone that signals your skin to make pigment. To understand the rest of this article, three quick terms help:

Melanotan I is the more targeted of the two. Its approved form, called afamelanotide, is a prescription product sold under the brand name Scenesse. Melanotan II is the broader, more potent version that became known online as a tanning peptide, and it remains an unapproved research compound. New to peptides in general? Our beginner's guide to peptides covers the fundamentals first.

Melanotan 1 vs 2: The Key Differences at a Glance

The fastest way to compare the two is side by side. The table below summarizes the differences this guide explains in detail.

How Melanotan 1 and Melanotan 2 Work

The core difference is receptor selectivity: Melanotan 1 mainly activates one receptor, while Melanotan 2 activates several. Both peptides bind to melanocortin receptors and trigger the same internal "make more pigment" signal that natural alpha-MSH does. The difference is how widely each one spreads that signal.

Melanotan 1 is highly selective for MC1R, the receptor on pigment cells (melanocytes) that controls eumelanin, the brown pigment behind a tan. Because it focuses on MC1R, its effects stay mostly tied to skin color. Melanotan 2 is non-selective. It activates MC1R for pigment, but it also activates MC3R, MC4R, and MC5R, which sit in areas of the body involved in appetite and sexual response. This is why Melanotan 2 produces effects far beyond tanning, as reviewed in preclinical and clinical research (Böhm et al., 2024).

Both peptides are far stronger than the hormone they copy.

That potency is what makes such tiny amounts active in research. It is also why side effects can appear quickly. Potency in a lab setting does not establish that either peptide is safe or appropriate for human cosmetic use.

Tanning Research: How the Two Compare

For pigment alone, research suggests Melanotan 2 darkens skin at lower cumulative amounts than Melanotan 1, but with a higher chance of side effects. In published reviews, Melanotan 2 reached increased pigmentation faster and at smaller total amounts, largely because it is more potent and hits the pigment receptor aggressively (Brennan et al., 2014). Melanotan 1 tends to produce a slower, more even darkening.

Both peptides are short-lived in the body, with a half-life of roughly 1.5 hours, which is why research uses repeated administration. Neither, however, is an approved cosmetic tanning product. Products marketed online are unregulated research chemicals, and their purity, strength, and contents can vary widely between sources. That uncertainty is a meaningful risk and a key reason health regulators advise against unprescribed use.

Beyond Tanning: What Else Melanotan 2 Has Been Studied For

Because Melanotan 2 activates receptors throughout the body, its research reaches well past skin pigment. Two areas appear most often in the literature.

Sexual-function research. Melanotan 2 acts on MC4R in the brain, a receptor involved in arousal. In early clinical research, a Melanotan 2 analogue produced erections in 17 of 20 men with psychogenic erectile dysfunction (Wessells et al., 1998), with a follow-up trial in men with organic erectile dysfunction (Wessells et al., 2000). These were small, early-stage studies and do not establish safety or any approved use. This line of work later led to a separate, FDA-reviewed compound, bremelanotide, which you can read about on our PT-141 page.

Appetite research. Through MC4R signaling, studies recorded roughly a 15% reduction in food intake. These are research observations only and are not evidence of a safe or effective product for changing body weight.

Melanotan 1, by contrast, stays narrowly focused on pigment and photoprotection. It has not shown the same body-wide effects, which is a direct result of its selectivity for MC1R.

Side Effects and Safety: Where They Differ

Melanotan 2's broader receptor activity is linked to more frequent and more varied side effects than Melanotan 1. The wider a peptide's reach, the more systems it can disturb.

Reported effects with Melanotan 2 include nausea, facial flushing, spontaneous erections, and reduced appetite. Melanotan 1 is associated with fewer systemic effects, sometimes only mild nausea or fatigue. Both peptides can darken existing moles and freckles, and whether either changes melanoma risk is still unclear in the research (Melanotan II, Wikipedia). Because moles can change with these peptides, any new or shifting mole is a reason to stop and seek a professional skin check. These observations come from limited research and case reports, not from large long-term safety studies.

Legal and Regulatory Status

Only Melanotan 1's approved form is FDA-cleared, and only for a rare medical condition. Afamelanotide (brand name Scenesse) received FDA approval in 2019 for adults with erythropoietic protoporphyria, a rare disorder that causes severe pain from light exposure (Scenesse, Drugs.com). It is delivered as an implant placed by a clinician, not as an over-the-counter product.

Melanotan 2 is not approved by the FDA for any use. Versions sold online are labeled for research only, and health authorities in several countries warn against buying or using unregulated tanning peptides. In short, the regulatory gap between the two is wide: one has a narrow approved medical form, the other has none.

Which Is "Better," Melanotan 1 or 2?

There is no universal "better." The right comparison depends entirely on what is being studied. Melanotan 1 is the selective, milder, pigment-focused peptide with an approved medical form. Melanotan 2 is the broader, more potent peptide that darkens skin at lower amounts but carries a wider range of side effects and body-wide activity. For a clean tanning-only research focus, selectivity favors Melanotan 1; for stronger pigment response at lower amounts, potency favors Melanotan 2, at the cost of more side effects.

Whichever you are researching, remember the framing behind the melanotan 1 vs 2 question: both are research compounds, neither is an approved cosmetic, and product quality on the unregulated market is unpredictable. For the complete molecular profiles, browse our full Melanotan I and Melanotan II pages linked above, and use the peptide dosage calculator for reconstitution and measurement math in a research setting.

Frequently Asked Questions

What is the difference between Melanotan 1 and Melanotan 2?

The main difference is receptor selectivity. Melanotan 1 mainly activates MC1R, the pigment receptor, so its effects stay close to skin color. Melanotan 2 activates MC1R plus MC3R, MC4R, and MC5R, so it affects pigment, appetite, and sexual response. Melanotan 2 is also more potent and has more side effects.

Is Melanotan 1 or 2 better for tanning?

In research, Melanotan 2 darkens skin at lower cumulative amounts because it is more potent, while Melanotan 1 produces a slower, more even darkening with fewer side effects. Neither is an approved cosmetic tanning product, and unregulated versions carry real quality and safety risks.

Which is safer, Melanotan 1 or Melanotan 2?

Based on reported side effects, Melanotan 1 has the narrower, milder profile because it targets a single receptor. Melanotan 2's broad receptor activity is linked to more frequent effects such as nausea, flushing, and spontaneous erections. Neither has large long-term human safety data, so neither can be called safe for cosmetic use.

Is Melanotan 1 safe?

Melanotan 1's approved form, afamelanotide, has an established safety profile only within its approved medical use and clinical monitoring. Unregulated, self-administered research versions do not have that oversight, and their purity is not guaranteed. Reported effects can include mild nausea, fatigue, and darkening of moles and freckles.

How long does it take to see results from Melanotan 1?

In research observations, initial skin darkening has been reported within roughly three to seven days, with more noticeable pigmentation over one to two weeks. These timelines come from research and user reports, not from controlled cosmetic studies, so individual results are not predictable.

Is Melanotan the same as melatonin?

No. The names look alike, but they are unrelated. Melatonin is a hormone tied to sleep, while the melanotan peptides act on pigment and melanocortin receptors. A search for "melatonin 1 vs melanotan 2" is almost always a mix-up of the two words.

Disclaimer

The information provided on Peptide Mind is for educational purposes only and is not a substitute for professional medical advice. Many peptides discussed on this site are unapproved research chemicals intended strictly for laboratory and preclinical use. The FDA has not evaluated these statements, and nothing on this site is intended to diagnose, treat, cure, or prevent any disease. By accessing this site, you confirm you are over the age of 21 and waive any claims or liability arising from the use of the content portrayed.

References